Next Article in Journal
A Fair Energy Allocation Algorithm for IRS-Assisted Cognitive MISO Wireless-Powered Networks
Next Article in Special Issue
Improving Breast Tumor Multi-Classification from High-Resolution Histological Images with the Integration of Feature Space Data Augmentation
Previous Article in Journal
Identifying Smartphone Users Based on Activities in Daily Living Using Deep Neural Networks
Previous Article in Special Issue
Chem2Side: A Deep Learning Model with Ensemble Augmentation (Conventional + Pix2Pix) for COVID-19 Drug Side-Effects Prediction from Chemical Images
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Metaverse Applications in Bioinformatics: A Machine Learning Framework for the Discrimination of Anti-Cancer Peptides

1
Department of Computer Science and Engineering, Sejong University, Seoul 05006, Republic of Korea
2
Institute of Computer Science and Information Technology, The Agriculture University Peshawar, Peshawar 25000, Pakistan
3
Department of Information and Communication Engineering and Convergence Engineering for Intelligent Drone, Sejong University, Seoul 05006, Republic of Korea
4
Department of Information Systems, College of Computer Engineering and Sciences, Prince Sattam Bin Abdulaziz University, Al-Kharj 16273, Saudi Arabia
5
Department of Computer Science, College of Computer Engineering and Sciences, Prince Sattam Bin Abdulaziz University, Al-Kharj 16273, Saudi Arabia
*
Author to whom correspondence should be addressed.
Information 2024, 15(1), 48; https://doi.org/10.3390/info15010048
Submission received: 7 December 2023 / Revised: 10 January 2024 / Accepted: 11 January 2024 / Published: 15 January 2024
(This article belongs to the Special Issue Applications of Deep Learning in Bioinformatics and Image Processing)

Abstract

Bioinformatics and genomics are driving a healthcare revolution, particularly in the domain of drug discovery for anticancer peptides (ACPs). The integration of artificial intelligence (AI) has transformed healthcare, enabling personalized and immersive patient care experiences. These advanced technologies, coupled with the power of bioinformatics and genomic data, facilitate groundbreaking developments. The precise prediction of ACPs from complex biological sequences remains an ongoing challenge in the genomic area. Currently, conventional approaches such as chemotherapy, target therapy, radiotherapy, and surgery are widely used for cancer treatment. However, these methods fail to completely eradicate neoplastic cells or cancer stem cells and damage healthy tissues, resulting in morbidity and even mortality. To control such diseases, oncologists and drug designers highly desire to develop new preventive techniques with more efficiency and minor side effects. Therefore, this research provides an optimized computational-based framework for discriminating against ACPs. In addition, the proposed approach intelligently integrates four peptide encoding methods, namely amino acid occurrence analysis (AAOA), dipeptide occurrence analysis (DOA), tripeptide occurrence analysis (TOA), and enhanced pseudo amino acid composition (EPseAAC). To overcome the issue of bias and reduce true error, the synthetic minority oversampling technique (SMOTE) is applied to balance the samples against each class. The empirical results over two datasets, where the accuracy of the proposed model on the benchmark dataset is 97.56% and on the independent dataset is 95.00%, verify the effectiveness of our ensemble learning mechanism and show remarkable performance when compared with state-of-the-art (SOTA) methods. In addition, the application of metaverse technology in healthcare holds promise for transformative innovations, potentially enhancing patient experiences and providing novel solutions in the realm of preventive techniques and patient care.
Keywords: artificial intelligence; machine learning; feature representation; classification; ensemble classifier; bioinformatics; metaverse; digital healthcare; sequence-based model; anticancer peptide artificial intelligence; machine learning; feature representation; classification; ensemble classifier; bioinformatics; metaverse; digital healthcare; sequence-based model; anticancer peptide

Share and Cite

MDPI and ACS Style

Danish, S.; Khan, A.; Dang, L.M.; Alonazi, M.; Alanazi, S.; Song, H.-K.; Moon, H. Metaverse Applications in Bioinformatics: A Machine Learning Framework for the Discrimination of Anti-Cancer Peptides. Information 2024, 15, 48. https://doi.org/10.3390/info15010048

AMA Style

Danish S, Khan A, Dang LM, Alonazi M, Alanazi S, Song H-K, Moon H. Metaverse Applications in Bioinformatics: A Machine Learning Framework for the Discrimination of Anti-Cancer Peptides. Information. 2024; 15(1):48. https://doi.org/10.3390/info15010048

Chicago/Turabian Style

Danish, Sufyan, Asfandyar Khan, L. Minh Dang, Mohammed Alonazi, Sultan Alanazi, Hyoung-Kyu Song, and Hyeonjoon Moon. 2024. "Metaverse Applications in Bioinformatics: A Machine Learning Framework for the Discrimination of Anti-Cancer Peptides" Information 15, no. 1: 48. https://doi.org/10.3390/info15010048

APA Style

Danish, S., Khan, A., Dang, L. M., Alonazi, M., Alanazi, S., Song, H.-K., & Moon, H. (2024). Metaverse Applications in Bioinformatics: A Machine Learning Framework for the Discrimination of Anti-Cancer Peptides. Information, 15(1), 48. https://doi.org/10.3390/info15010048

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop